Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mills

Showing results (1121-1130 of 1,298) with videos related to

Pageof 130
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2016
Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocolF Meric-Bernstam, L Brusco, M Daniels, et al.
Oncotarget|November 22, 2014
Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patientsAnna Berg, Erling A Hoivik, Siv Mjøs, et al.
Journal of Oncology Practice|March 2, 2011
Effect of initiating a multidisciplinary care clinic on access and time to treatment in patients with pancreatic adenocarcinomaTimothy B Gardner, Richard J Barth, Bassem I Zaki, et al.
Nature Communications|July 18, 2018
In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancerCaitlin L Grzeskowiak, Samrat T Kundu, Xiulei Mo, et al.
The Journal of Clinical Investigation|November 15, 2021
Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinomaNan Jin, Bhumsuk Keam, Janice Cho, et al.
Life Science Alliance|May 9, 2020
MAPK pathway mutations in head and neck cancer affect immune microenvironments and ErbB3 signalingHoi-Lam Ngan, Yuchen Liu, Andrew Yuon Fong, et al.
Clinical Proteomics|June 22, 2011
A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast CancersBryan T Hennessy, Yiling Lu, Ana Maria Gonzalez-Angulo, et al.
Clinical Proteomics|September 13, 2011
Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancerAna M Gonzalez-Angulo, Bryan T Hennessy, Funda Meric-Bernstam, et al.
Breast Cancer Research : BCR|July 12, 2014
Peroxiredoxin-1 protects estrogen receptor α from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancerPatrick C O'Leary, Marta Terrile, Malgorzata Bajor, et al.
Oncotarget|November 3, 2016
Clinical outcomes based on multigene profiling in metastatic breast cancer patientsReva K Basho, Debora de Melo Gagliato, Naoto T Ueno, et al.
Pageof 130

Showing results (1121-1130 of 1,298) with videos related to

Sort By:
Pageof 130
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2016
Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocolF Meric-Bernstam, L Brusco, M Daniels, et al.
Oncotarget|November 22, 2014
Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patientsAnna Berg, Erling A Hoivik, Siv Mjøs, et al.
Journal of Oncology Practice|March 2, 2011
Effect of initiating a multidisciplinary care clinic on access and time to treatment in patients with pancreatic adenocarcinomaTimothy B Gardner, Richard J Barth, Bassem I Zaki, et al.
Nature Communications|July 18, 2018
In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancerCaitlin L Grzeskowiak, Samrat T Kundu, Xiulei Mo, et al.
The Journal of Clinical Investigation|November 15, 2021
Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinomaNan Jin, Bhumsuk Keam, Janice Cho, et al.
Life Science Alliance|May 9, 2020
MAPK pathway mutations in head and neck cancer affect immune microenvironments and ErbB3 signalingHoi-Lam Ngan, Yuchen Liu, Andrew Yuon Fong, et al.
Clinical Proteomics|June 22, 2011
A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast CancersBryan T Hennessy, Yiling Lu, Ana Maria Gonzalez-Angulo, et al.
Clinical Proteomics|September 13, 2011
Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancerAna M Gonzalez-Angulo, Bryan T Hennessy, Funda Meric-Bernstam, et al.
Breast Cancer Research : BCR|July 12, 2014
Peroxiredoxin-1 protects estrogen receptor α from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancerPatrick C O'Leary, Marta Terrile, Malgorzata Bajor, et al.
Oncotarget|November 3, 2016
Clinical outcomes based on multigene profiling in metastatic breast cancer patientsReva K Basho, Debora de Melo Gagliato, Naoto T Ueno, et al.
Pageof 130